Sara brings over 16 years of experience in the cell and gene therapy field, with deep expertise in CMC regulatory strategy and global regulatory affairs. She has built a career distinguished by her ability to integrate technical CMC expertise with strategic regulatory insights, enabling cross-functional teams to streamline operations and accelerate development timelines.